5
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Increased activity of 5′nucleotidase in serum of patients with sickle cell anaemia

, &
Pages 701-704 | Received 03 Dec 1992, Accepted 24 Jun 1993, Published online: 08 Jul 2009
 

Abstract

Mohamed A. O., Jansson A., Ronquist G. Increased activity of 5′nucleotidase in serum of patients with sickle cell anaemia. Scand J Clin Lab Invest 1993; 53: 701-704

Fifty-nine patients with homozygous sickle cell anaemia, 17 heterozygous individuals and 22 controls were investigated in respect to serum (S) 5′nucleotidase (5′NT, EC 3.1.3.5). The patients showed a significantly higher mean value of S-5′NT compared to the controls. However, this rise was heterogeneous as it occurred only among a subgroup of patients. The heterozygous individuals were not different from either the patients or the controls generating a situation which puts the heterozygous individuals in an intermediate position between the patients and the controls. S-5′NT showed significant correlation with S-bilirubin, S-aspartate aminotransferase, S-alanine aminotransferase and especially S-gammaglutamyl transferase. However, it was not correlated with S-alkaline phosphatase, which is another marker for hepatobiliary disease. These results suggest that the liver involvement in a subgroup of patients with sickle cell anaemia is a mixture of hepatocyte damage and the biliary tree involvement.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.